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In-vivo correlations between 
skin metabolic oscillations and 
vasomotion in wild-type mice and 
in a model of oxidative stress
Salvatore Smirni1, Alison D. McNeilly1, Michael P. MacDonald1,2, Rory J. McCrimmon1 & 
Faisel Khan1
Arterioles in the cutaneous microcirculation frequently display an oscillatory phenomenon defined 
vasomotion, consistent with periodic diameter variations in the micro-vessels associated with 
particular physiological or abnormal conditions. The cellular mechanisms underlying vasomotion and 
its physiological role have not been completely elucidated. Various mechanisms were demonstrated, 
based on cell Ca2+ oscillations determined by the activity of channels in the plasma membrane or 
sarcoplasmic reticulum of vascular cells. However, the possible engagement in vasomotion of cell 
metabolic oscillations of mitochondrial or glycolytic origin has been poorly explored. Metabolic 
oscillations associated with the production of ATP energy were previously described in cells, while 
limited studies have investigated these fluctuations in-vivo. Here, we characterised a low-frequency 
metabolic oscillator (MO-1) in skin from live wild-type and Nrf2−/− mice, by combination of fluorescence 
spectroscopy and wavelet transform processing technique. Furthermore, the relationships between 
metabolic and microvascular oscillators were examined during phenylephrine-induced vasoconstriction. 
We found a significant interaction between MO-1 and the endothelial EDHF vasomotor mechanism 
that was reduced in the presence of oxidative stress (Nrf2−/− mice). Our findings suggest indirectly 
that metabolic oscillations may be involved in the mechanisms underlying endothelium-mediated skin 
vasomotion, which might be altered in the presence of metabolic disturbance.
The term vasomotion indicates rhythmic oscillations of blood vessels diameter responsible for changes in the 
vascular tone and blood perfusion to tissue1,2. The physiological role of these oscillations is unclear, with con-
trasting studies supporting the development of vasomotion in both diseased and healthy conditions2. The origin 
of the oscillations is mainly determined by the local contraction and relaxation of vascular smooth muscle cells 
(VSMCs), which act as synchronised pacemakers in the vessels wall1–3. Although in several arteries (e.g. rat aorta) 
the oscillations may depend exclusively on the activity of VSMCs1, in other vascular beds (i.e. rat mesenteric 
artery) the most internal layer of blood vessels (endothelium) plays an important modulatory role during arterial 
motion4,5. Vasomotion is more prominent in small resistance micro-vessels2 such as skin arterioles that represent 
an optimal sample for the in-vivo examination of this phenomenon reflecting the general health conditions of the 
cardiovascular system6.
Non-invasive observation of skin vasomotion can be achieved by direct methods measuring vessels diameter, e.g. 
intravital video-microscopy3,4, or by indirect techniques such as Laser Doppler Flowmetry (LDF) based on moni-
toring the heterogeneous fluctuations of microvascular blood perfusion signal2. The combination of LDF with the 
wavelet transform signal processing analysis has revealed oscillations in the human cutaneous microcirculation that 
relate to physiological phenomena: myogenic (52–145 × 10−3 Hz), neurogenic (21–52 × 10−3 Hz), endothelial nitric 
oxide (NO)-dependent (9.5–21 × 10−3 Hz), and endothelial NO-independent (5–9.5 × 10−3 Hz)7,8.
For the explanation of the cellular mechanisms causing the oscillations of vessels diameter observed during 
vasomotion, three different kinds of cellular oscillators have been proposed as possible drivers of this phenom-
enon: cytosolic oscillator, membrane oscillator and metabolic oscillator1,2. The importance of the cooperation 
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between cytosolic and membrane oscillators to enhance the VSMCs synchronisation responsible for vasomo-
tion has been largely explored and recognised1,2,9–12. They act inducing Ca2+ fluctuations in VSMCs, respectively 
through the oscillatory release of Ca2+ from the sarcoplasmic reticulum1,10,11, and via the opening activity of 
voltage-dependent Ca2+ channels and large-conductance K+ channels of the plasma membrane1,2,12. Furthermore, 
Ca2+ and membrane potential oscillations have been described in endothelial cells (ECs), suggesting that in some 
vascular beds (i.e. rat mesenteric artery) in response to specific stimuli (e.g. α-adrenergic stimulation) a primary 
oscillation from ECs and the interaction with VSMCs might be essential for vasomotion13–15.
A third hypothesised driving mechanism is the presence of a metabolic oscillator represented by oscillations 
in the activity of the glycolytic enzyme phosphofructokinase (PFK) that cause fluctuations in glycolysis, ATP 
levels and in the activity of plasma membrane ion channels and membrane potential1. This mechanism has never 
been considered important because of limited experimental evidence for the involvement of PFK in glycolytic 
and Ca2+ fluctuations1,2. However, recent studies have strongly suggested the participation of PFK in reactions 
responsible for glycolysis and Ca2+ oscillations16–18, with a possible driving effect exerted in-vivo by external 
glucose availability and uptake18–20. Furthermore, metabolic mitochondrial oscillations have also been reported, 
mainly associated with fluctuations of the mitochondrial membrane potential ΔΨm that may be mediated by 
calcium21–23. The external oxygen required for sustaining the electron transport chain has been proposed as the 
driving force for the mitochondrial oscillator18. All this evidence suggests that the energetic and oxygen tissue 
requirements might stimulate vasomotion phenomena associated with Ca2+ oscillations of metabolic origin, 
which may involve the intercellular communication between heterogeneous groups of cells (e.g. ECs, VSMCs and 
cells of the tissue surrounding blood vessels).
Metabolic oscillations have been studied in different cell types, i.e. yeast Saccharomyces cerevisiae19,21, cardiac 
myocytes24, β-cells23, and can be detected indirectly by measuring the fluctuations in the autofluorescence of 
the intermediate product of energy metabolism NAD(P)H (nicotamide adenine dinucleotide). However, there 
are limited studies describing metabolic oscillations in live tissue. Mitochondrial fast oscillations have been 
reported in-vivo in rat, and detected by intravital two-photon (2P) microscopy measurements of NAD(P)H25. 
Nevertheless, to our knowledge, the slow metabolic NAD(P)H oscillations described in many in-vitro or ex-vivo 
cell studies16,23 have not been investigated in-vivo.
In the present study, we have utilised skin tissue from live mice to simultaneously measure NAD(P)H and 
microvascular blood flow respectively by laser fluorescence spectroscopy (LFS) and LDF, under physiological 
conditions and during α-adrenergic stimulation with the vasoconstrictor drug phenylephrine (PE). Data were 
processed by continuous wavelet transform (CWT) spectral analysis to characterise heterogeneous oscillations 
of NAD(P)H and LDF signals. We found low-frequency oscillations of NAD(P)H autofluorescence with periods 
of 2.4 min, 5 min and 10 min. To our knowledge, this is the first study in live skin tissue of slow NAD(P)H oscilla-
tions previously described in cells. Furthermore, we found relevant correlations between metabolic and vasomo-
tion oscillations suggesting a link between these processes. Therefore, our results support the idea of vasomotion 
as a dynamic process in the context of a metabolically active microvascular network involving the cooperation of 
different cell types and vascular segments2,15, and a possible driving mechanism of metabolic origin.
Results
Nrf2−/− (Nuclear factor-erythroid 2 p45-related factor 2) knockout model. Experiments were per-
formed on 5 wild-type (WT) control and 6 Nrf2−/− mice. The Nrf2 transcription factor is a key regulator of the cell 
redox state, involved in the resistance to oxidative stress by activating the cellular antioxidant defence26. Nrf2 knock-
out leads to abnormal mitochondrial activity, altered redox status, increased oxidative stress, and has an impact on 
cardiovascular dynamics26,27. We used the Nrf2−/− strain to investigate the differences in metabolic and vascular 
dynamics between normal mice and animals with impaired antioxidant defence that may favour the development 
of metabolic and cardiovascular disorders. Figure 1 shows the experimental setup (Fig. 1a), and examples of simul-
taneous LFS and LDF signals (Fig. 1c,d) from the flank of a mouse at baseline (10 min) and during vasoconstriction 
induced by local administration of PE (10 min). The reason for using PE is that, according to Okazaki et al.5, this 
vasoactive agent is able to stimulate a vasomotion phenomenon mediated by endothelial cells. Thus, the use of PE 
provided the opportunity to study at the same time the role of the endothelium in vasomotion and its relationship 
with metabolic oscillations. Because of the small number of animals available in the study, the experiments were 
repeated in duplicate for each mouse and the average value of each variable between the two experiments was taken 
as final value for data analysis. Data of all the variables analysed in this study are summarised in Table 1.
General microvascular and metabolic biomarkers. Results of blood perfusion and oxygen satura-
tion (SO2) are shown in Fig. 2a,b. Blood perfusion decreased to a similar degree in WT (p = 0.046) and Nrf2−/− 
(p = 0.007) mice during PE-induced vasoconstriction, however, a stronger p-value was found in knockout mice. 
SO2, measured by reflectance spectroscopy (RS), was similar between groups and decreased slightly following 
vasoconstriction without statistical significance.
LFS skin irradiation by UV light stimulates the autofluorescence emission of multiple fluorophores, including 
NAD(P)H (490 nm), flavin adenine dinucleotide (FAD+, 550 nm) and elastin (450 nm) (Fig. 1b). Although the 
NAD(P)H central emission peak represents the highest contribution to the spectrum, we took advantage of the 
overlapping contributions from FAD+ and elastin, respectively to estimate the redox ratio (RR) index and to 
normalise NAD(P)H fluorescence:
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RRindex is a measure of the mitochondrial redox state, reflecting the balance between the reduced NAD(P)
H and the oxidised FAD+ coenzymes. Comparing this index between WT and Nrf2−/− mice should provide 
discriminatory data, confirming that the Nrf2−/− phenotype is characterised by altered mitochondrial function 
Figure 1. Example of data collection from mouse skin. (a) Experimental setup for LFS and LDF recordings 
during local transdermal administration of 1% phenylephrine by iontophoresis. (b) Example of single UV 
discrete autofluorescence spectrum measured by LFS. (c) Example of 20 min NAD(P)H signal reconstructed 
by piecewise cubic spline interpolation of NAD(P)Hnormalised values extracted from 10 baseline UV spectra and 
10 UV spectra collected during PE administration. (d) Example of 20 min blood flow tracing measured by LDF 
during iontophoresis.
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due to impaired antioxidant defence and higher oxidative stress. NAD(P)H autofluorescence was normalised by 
elastin’s fluorescence peak to reduce blood volume artefacts (see more details in the Supplementary Information).
During each experiment, 20 UV spectra were collected in 20 min at a rate of a spectrum every minute, 10 at 
baseline and 10 during PE administration. RRindex and NAD(P)Hnormalised values were estimated from each spec-
trum and used to reconstruct a time series (Fig. 1c) for applying the CWT spectral analysis. Figure 2c,d describe 
the average trends of NAD(P)Hnormalised and RRindex signals. NAD(P)Hnormalised did not show significant statistical 
differences between groups, while RRindex was significantly lower in Nrf2−/− mice (p = 0.016) confirming that 
knockout animals were affected by altered redox state and higher oxidative stress.
Reproduction of the LDF oscillators reported in the literature. Vasomotion oscillations were 
assessed by combining LDF and CWT techniques8,28,29. We found oscillatory frequency intervals related to 
tissue/cell activity similar to those reported in human studies: myogenic (50–150 × 10−3 Hz), neurogenic (20–
50 × 10−3 Hz), endothelial NO-dependent (9–20 × 10−3 Hz), endothelial NO-independent (5–9 × 10−3 Hz) 
(Fig. 3a). In contrast, cardiac (1350–5000 × 10−3 Hz) and respiratory (150–1350 × 10−3 Hz) components showed 
higher frequency ranges (Fig. 3a), confirming the faster heart and breathing rates expected for mice30,31. Although 
the magnitude of the oscillations could be reduced due to the effects of anaesthesia32, we used a light isoflurane 
anaesthesia to avoid major systemic effects on the circulation. Additionally, all mice were scanned under the same 
conditions thus making it possible to compare differences between groups.
CWT allows the identification of two oscillators reflecting ECs activity. While the biological link between 
the 9–20 × 10−3 Hz oscillator and the endothelial NO mechanism has been demonstrated33, the origin of the 
5–9 × 10−3 Hz oscillator (endothelial NO-independent) is ambiguous. However, our results and literature 
reports28,29 suggest indirectly an association with the endothelial-derived hyperpolarizing factor (EDHF) vasodi-
lation mechanism, thus here we will refer to the endothelial NO-independent component as EDHF. The reasons 
supporting this hypothesis are explained in the Supplementary Information.
Parameters WT (Mean ± SD) Nrf2−/− (Mean ± SD)
Variable name Baseline Phenylephrine Baseline Phenylephrine
Blood perfusion [PU] 174.0 ± 30.40 162.8 ± 26.80 197.6 ± 20.50 184.0 ± 16.70
SO2 [%] 47.3 ± 9.60 44.9 ± 10.7 48.3 ± 9.60 45.5 ± 6.10
NAD(P)Hnormalised 1.7 ± 0.2 1.7 ± 0.2 1.9 ± 0.2 1.8 ± 0.1
RRindex 2.2 ± 0.1 2.2 ± 0.1 2.0 ± 0.1 2.0 ± 0.1
ei Endothelial EDHF (0.70 ± 0.20) × 10−3 (0.40 ± 0.10) × 10−3 (0.40 ± 0.20) × 10−3 (0.60 ± 0.30) × 10−3
ei Endothelial NO (1.10 ± 0.30) × 10−3 (0.60 ± 0.20) × 10−3 (0.80 ± 0.30) × 10−3 (1.00 ± 0.50) × 10−3
ei Neurogenic (1.90 ± 0.80) × 10−3 (1.00 ± 0.30) × 10−3 (1.30 ± 0.40) × 10−3 (1.50 ± 0.80) × 10−3
ei Myogenic (4.50 ± 1.50) × 10−3 (3.20 ± 1.10) × 10−3 (3.40 ± 0.60) × 10−3 (3.80 ± 1.10) × 10−3
ai Endothelial EDHF (11.0 ± 2.30) × 10−3 (6.10 ± 1.50) × 10−3 (7.10 ± 4.10) × 10−3 (8.90 ± 4.00) × 10−3
ai Endothelial NO (10.6 ± 4.40) × 10−3 (6.00 ± 2.60) × 10−3 (7.60 ± 3.90) × 10−3 (9.50 ± 5.60) × 10−3
ai Neurogenic (12.9 ± 7.60) × 10−3 (5.50 ± 1.80) × 10−3 (8.40 ± 1.90) × 10−3 (8.40 ± 4.70) × 10−3
ai Myogenic (14.8 ± 6.60) × 10−3 (9.70 ± 4.30) × 10−3 (11.2 ± 2.40) × 10−3 (12.4 ± 5.30) × 10−3
fEndothelial EDHF [Hz] (8.00 ± 0.60) × 10−3 (6.90 ± 0.90) × 10−3 (6.30 ± 1.00) × 10−3 (7.70 ± 0.80) × 10−3
fEndothelial NO [Hz] (1.40 ± 0.10) × 10−2 (1.50 ± 0.30) × 10−2 (1.40 ± 0.20) × 10−2 (1.50 ± 0.20) × 10−2
fNeurogenic [Hz] (2.80 ± 0.50) × 10−2 (3.00 ± 0.70) × 10−2 (3.50 ± 1.00) × 10−2 (4.00 ± 1.00) × 10−2
fMyogenic [Hz] (10.4 ± 1.30) × 10−2 (9.30 ± 2.10) × 10−2 (9.20 ± 1.70) × 10−2 (9.20 ± 1.60) × 10−2
ei NAD(P)H MO–1 (12.8 ± 1.40) × 10−3 (16.1 ± 1.50) × 10−3 (12.3 ± 4.60) × 10−3 (15.8 ± 2.40) × 10−3
ei RR MO–1 (11.7 ± 4.60) × 10−3 (14.9 ± 2.50) × 10−3 (14.6 ± 3.90) × 10−3 (12.0 ± 3.10) × 10−3
ai NAD(P)H MO–1 (10.7 ± 2.70) × 10−3 (11.7 ± 3.50) × 10−3 (9.60 ± 5.40) × 10−3 (13.8 ± 5.50) × 10−3
ai RR MO–1 (8.10 ± 4.40) × 10−3 (12.4 ± 2.30) × 10−3 (11.2 ± 3.90) × 10−3 (8.60 ± 4.20) × 10−3
fNAD(P)H MO–1 [Hz] (6.10 ± 1.10) × 10−3 (6.60 ± 0.60) × 10−3 (6.80 ± 1.40) × 10−3 (6.30 ± 0.90) × 10−3
fRR MO–1 [Hz] (6.70 ± 1.10) × 10−3 (6.40 ± 1.20) × 10−3 (6.30 ± 0.80) × 10−3 (7.00 ± 1.30) × 10−3
CφNAD(P)H MO–1/EDHF 0.78 ± 0.03 0.76 ± 0.05 0.76 ± 0.05 0.79 ± 0.05
CφRR MO–1/EDHF 0.79 ± 0.04 0.76 ± 0.02 0.74 ± 0.06 0.78 ± 0.02
Table 1. Average values of all the variables included in the study. Data are presented as mean ± Standard Deviation 
(SD). PU = Perfusion arbitrary units. SO2 = Oxygen saturation (%). NAD(P)Hnormalised = Autofluorescence of 
the reduced nicotamide adenine dinucleotide coenzyme, normalised according to equation 2 (dimensionless). 
RRindex = Redox ratio index obtained according to equation 1 (dimensionless). ei = Relative energy of wavelet 
oscillators (dimensionless). ai = Relative amplitude of wavelet oscillators (dimensionless). f = frequency of wavelet 
oscillators (Hz). LDF oscillators: endothelial EDHF, endothelial NO, neurogenic, myogenic. Metabolic oscillators: 
NAD(P)H MO-1, RR MO-1. CφNAD(P)H MO–1/EDHF = Phase coherence (dimensionless) between NAD(P)H MO-1 
and endothelial EDHF oscillators. CφRR MO–1/EDHF = Phase coherence (dimensionless) between RR MO-1 and 
endothelial EDHF oscillators.
www.nature.com/scientificreports/
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Characterisation of metabolic fluctuations. In-vivo metabolic oscillations were detected by CWT 
analysis of NAD(P)Hnormalised and RRindex reconstructed signals. Figure 3b shows an example of CWT scalogram 
and the corresponding time-averaged spectrum from NAD(P)H signal. High spectral energy was found in the 
low-frequency ranges, thus slow oscillators dominate the reconstructed tracing. Although time resolution is 
scarce in the low frequencies, we clearly identified three heterogeneous oscillatory intervals defined metabolic 
oscillator-1 (MO-1) (5–9 × 10−3 Hz), metabolic oscillator-2 (MO-2) (2.5–5 × 10−3 Hz) and metabolic oscillator-3 
(MO-3) (1.5–2.5 × 10−3 Hz). However, we will discuss only results of MO-1 because MO-2 and MO-3 frequency 
ranges fall largely at the edges of the cone of influence region in the CWT scalogram, where data might not be 
reliable34 (see caption of Fig. 3 for more details).
LDF oscillators’ changes during vasomotion and comparison between groups. Figure 4 describes 
the quantitative results of the relative spectral energy ei and frequency f extracted from the time-averaged wavelet 
peak of each LDF oscillator. The relative ei, to allow comparisons between groups, was obtained by normalising 
the absolute energy extracted from the peak of each oscillator (Ei, area under the curve) by the total absolute 
energy Etot of the wavelet spectrum and the number of frequencies in the interval of the oscillator.
The spectral ei and frequency of the EDHF endothelial oscillator were significantly greater in WT mice at 
baseline (energy p = 0.03, frequency p = 0.005). The EDHF energy and frequency changed significantly in both 
groups during PE stimulation following opposite trends. The values increased in Nrf2−/− mice (energy p = 0.01, 
frequency p = 0.02) and decreased in controls (energy p = 0.008, frequency p = 0.04). The endothelial NO oscil-
lator displayed the same trends observed for the EDHF oscillation. However, we found statistical significance only 
for the decrease of energy during phenylephrine delivery in WT mice (p = 0.008). The neurogenic and myogenic 
components showed patterns similar to those of the endothelial oscillations. The energy was reduced in normal 
mice after PE administration, with a good p-value for the neurogenic oscillator (p = 0.04) and a p-value close to 
statistical significance for the myogenic component (p = 0.08). We evaluated also the relative maximal amplitude 
ai of the wavelet peaks, estimated by normalising the absolute amplitude Ai of each oscillator by the total ampli-
tude Atot of the wavelet spectrum and the number of frequencies in the interval of the oscillator. The data of ai are 
summarised in Table 1 and displayed the same patterns found for ei but with lower statistical significance.
These results outline opposite microvascular reactivity to PE in WT and Nrf2−/− mice, especially for the 
endothelial components that are key factors determining microvascular function. This suggests that oxidative 
stress may affect endothelial function and the overall cardiovascular dynamics in the long term.
In general, the increase of LDF oscillators’ spectral energy reflects vasodilation dynamics28,29,33, thus the 
expected oscillatory pattern during mild vasoconstriction (1% PE) should be a decrease of ei, as observed in WT 
Figure 2. Average trends of microvascular and metabolic biomarkers. (a) Blood flow (PU). (b) SO2 (%). (c) 
NAD(P)Hnormalised (dimensionless). (d) RRindex (dimensionless). Error bars = 2 standard errors (SE). Black 
bars = Baseline. White bars = PE. WT = Control. Nrf2−/− = Knockout. Black lines/asterisks = Significant 
changes during PE delivery. Red lines/asterisks = Significant differences between groups. t-test *p < 0.05, 
**p < 0.01.
www.nature.com/scientificreports/
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animals. In contrast, Nrf2−/− mice displayed an increase of LDF oscillators’ ei during phenylephrine administra-
tion. The reason for this behaviour might be the activation of an endothelium-mediated vasomotion resistance 
mechanism to attenuate vasoconstriction defined myoendothelial feedback15, consistent with the alternation of 
vasoconstriction and vasodilation induced respectively by simultaneous targeting of VSMCs with PE and EDHF/
NO endothelial signalling. The cause for the activation of this mechanism may be a general major vasoconstric-
tion in micro-vessels affected by oxidative stress. We cannot exclude that also WT mice may activate this mecha-
nism in response to higher vasoconstriction stimuli (PE > 1%).
Metabolic oscillations’ changes and comparison between groups. Data of the spectral ei, ai and f of 
NAD(P)H MO-1 and RR MO-1 wavelet peaks are summarised in Fig. 5a–c. Only WT mice showed a statistically 
significant increase of NAD(P)H MO-1 ei (p = 0.01) and RR MO-1 ai (p = 0.04) during PE delivery. The baseline 
RR MO-1 amplitude ai was lower in WT compared to Nrf2−/− mice (p = 0.097), while differences in frequencies 
were not relevant.
NAD(P)Hnormalised and RRindex oscillations reflect the cellular oxido-reductive dynamics, consistent with the 
turnover between the oxidised and reduced forms of NAD(P)H and FADH2 coenzymes as part of the cyclic reac-
tions for the production of ATP energy during glycolysis and oxidative phosphorylation (OXPHOS) processes. 
Figure 3. CWT data processing of LDF and NAD(P)H signals. (a) Example of CWT scalogram (left) and 
corresponding time-averaged spectrum (right) from LDF signal. The scalogram describes the distribution of the 
wavelet spectral power/energy in the time-frequency domain using a gradient coloured map ranging from dark 
blue (low energy) to dark red (high energy). The chart displays a high-energy continuous band in the cardiac 
frequency interval, confirming that data were collected correctly. Physiologically, the wavelet energy represents 
a measure of how much a physiological component defined by a specific frequency interval contributes to 
blood flow signal at a specific time. The two transparent regions at the bottom-right and bottom-left of the 
scalogram represent regions outside of the “cone of influence” where data might not be reliable (frequencies 
< 5 × 10−3 Hz). The cone of influence is a time-frequency region where distortions of the CWT due to the 
finite temporal period of the measured signal are not relevant34. Instead, the areas outside of the cone are close 
to the time limits of the time series, where the wavelet transform is affected by boundary effects making the 
calculations from this time-frequency region imprecise34. The time-averaged spectrum (right graph) allows 
discriminating the wavelet energy peaks of the different oscillators at specific frequency intervals. As shown 
by the coloured tags in the legend, we identified the typical oscillators reported in literature8: (I) Cardiac, 
(II) Respiratory, (III) Myogenic, (IV) Neurogenic, (V) Endothelial NO-dependent, (VI) Endothelial NO-
independent (EDHF). Comparing the wavelet components between mice groups is powerful to distinguish 
healthy and diseased vascular conditions by quantifying the contribution of specific biological components. 
(b) Example of CWT analysis of the NAD(P)Hnormalised reconstructed signal. Three low-frequency metabolic 
oscillators were characterised: Metabolic oscillator-1 (MO-1), MO-2 and MO-3. These oscillators might reflect 
specific dynamic patterns of ATP energy production in the cutaneous tissue, which may be variable depending 
on the presence of healthy or diseased conditions. In this study, we focused on the dynamics of MO-1 because 
MO-2 and MO-3 intervals are located outside of the cone of influence where data might be inaccurate.
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The results of the spectral analysis outline different dynamics of metabolic oscillators in WT and Nrf2−/− mice, 
especially for the RR MO-1. Considering that RRindex reflects mitochondrial function, the major discriminatory 
power of RR MO-1 may indicate abnormal mitochondrial energetic dynamics in Nrf2−/− mice due to increased 
amounts of reactive oxygen species (ROS) affecting the electron transport chain.
Wavelet phase coherence (WPCO). The WPCO analysis allows investigating the phase relationship 
Cφ(ωk) between oscillations in a specific frequency range of two signals measured simultaneously. We used 
WPCO to explore the phase interaction between the endothelial EDHF oscillator and the MO-1 of NAD(P)
Figure 4. Results of LDF oscillators. (a) Mean relative energy ei (dimensionless) of the wavelet peaks. (b) Mean 
frequency f (Hz) of the wavelet peaks. Error bars = 2 SE. Black bars = Baseline. White bars = PE. WT = Control. 
Nrf2−/− = Knockout. Black lines/asterisks = Significant changes during PE administration. Red lines/
asterisks = Significant differences between groups. t-test *p < 0.05, **p < 0.01.
www.nature.com/scientificreports/
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Figure 5. Results of metabolic oscillators and WPCO analysis. (a) Mean energy ei (dimensionless), (b) mean 
amplitude ai (dimensionless), and (c) mean f (Hz) of NAD(P)H and RR MO-1 wavelet peaks. (d) Average phase 
coherence Cφ(ωk) (dimensionless) between NAD(P)H or RR MO-1 and the endothelial EDHF oscillator. The 
WPCO analysis is useful to study the phase relationship between low-frequency oscillators, which cannot be 
performed using the analysis of synchronisation due to the noisy background in the slow CWT components. 
Error bars = 2 SE. Black bars = Baseline. White bars = PE. WT = Control. Nrf2−/− = Knockout. Black lines/
asterisks = Significant changes during PE delivery. Red lines/asterisks = Significant differences between groups. 
t-test *p < 0.05, **p < 0.01.
www.nature.com/scientificreports/
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Hnormalised (CφNAD(P)H MO–1/EDHF) or RRindex (CφRR MO–1/EDHF) signals, which fall in the same low-frequency interval 
(5–9 × 10−3 Hz). Because our analysis does not include the surrogate data testing described recently by Gruszecki 
et al.35, we cannot make reliable assumptions on the degree of coherence at rest due to bias affecting the low fre-
quencies. However, we can cautiously compare differences between mice phenotypes and changes in response to 
PE stimulation. Non-significant differences were found for the CφNAD(P)H MO–1/EDHF (Fig. 5d). In contrast, baseline 
CφRR MO–1/EDHF was significantly lower in Nrf2−/− mice (p = 0.005), and changed significantly in both groups dur-
ing PE administration showing a decrease in WT animals (p = 0.01) and an increase in Nrf2−/− mice (p = 0.003) 
(Fig. 5d). These results outline again a major discriminatory power of RR MO-1 compared to NAD(P)H MO-1, 
suggesting that oxidative stress may impact the interaction/coupling between mitochondrial reactions and the 
EDHF vasodilation mechanism affecting vascular reactivity to PE.
Relevant correlations. Correlations in WT mice. Figure 6 displays the correlations between microvas-
cular and metabolic variables observed in WT mice. Due to the small number of animals (n = 5) available in 
the study, separating baseline and PE data in two distinct subgroups would reduce the statistical power, thus we 
have pooled all the data in a single correlation analysis. However, for completeness of information the results are 
presented for the pooled group (baseline + PE, n = 10) and the separate baseline and PE subgroups (n = 5, statis-
tical power < 0.8). The pooled analysis revealed significant negative correlations between the EDHF ei and both 
NAD(P)H MO-1 ei (r = −0.82, p = 0.003) and RR MO-1 ai (r = −0.80, p = 0.002). NAD(P)H MO-1 ei showed 
also high negative correlations with the energy of endothelial NO (r = −0.77, p = 0.008), neurogenic (r = −0.70, 
p = 0.02) and myogenic (r = −0.70, p = 0.03) oscillators, and the RR MO-1 ai was negatively related to blood 
perfusion (r = −0.70, p = 0.03). None of these correlations were observed in Nrf2−/− mice. These results outline 
a robust association between the oxido-reductive fluctuations of NAD(P)H and FADH2 involved in ATP biosyn-
thesis and the activation/inactivation of microvascular regulatory mechanisms. Indeed, the correlations probably 
indicate that in response to 1% PE the spectral energy of vascular oscillators decreases as the energy of slow met-
abolic oscillators increases. This may reflect a change in the turnover between NAD(P)+ and NAD(P)H promot-
ing the inhibition of EDHF/NO endothelium-mediated vasodilation, and the enhancement of VSMCs-mediated 
vasoconstriction.
In spite of reduced statistical power, the analysis of correlations for the single baseline and PE subgroups 
provided useful additional information, indicating which are the correlations mostly associated with the base-
line and PE time points. Significant negative correlations were found between the endothelial EDHF ei and the 
NAD(P)H MO-1 ei (r = −0.79, p = 0.04) or the RR MO-1 ai (r = −0.84, p = 0.04) in the PE subgrop. These obser-
vations suggest that the metabolic oxido-reductive dynamics may be involved especially in the modulation of the 
EDHF pathway during α-adrenergic stimulation. In contrast, the endothelial NO and myogenic ei showed a more 
significant correlation with NAD(P)H ei in the baseline subgroup (r = −0.72, p = 0.16 and r = −0.90, p = 0.04 
respectively).
Correlations in Nrf2−/− mice. Figure 7 displays the most important correlations observed in Nrf2−/− mice. Also 
in this case due to the small number of animals (n = 6), the results are presented either as pooled group (base-
line + PE, n = 12) and separate baseline and PE subgroups (n = 6). The main correlations found in the pooled 
group were related to the wavelet frequency f of the endothelial NO oscillator, which was positively correlated 
with NAD(P)H MO-1 ei (r = 0.60, p = 0.04) and negatively correlated with SO2 (r = −0.60, p = 0.03). These cor-
relations might reflect the overexpression of the endothelial nitric oxide synthase (eNOS) enzyme described 
previously in Nrf2−/− mice27, leading to major production of NO probably to balance for dysfunction in other 
vasodilation pathways preserving vascular function in vessels affected by oxidative stress27. The correlations may 
be consistent with this evidence because both NADPH and molecular oxygen participate in the reaction for NO 
biosynthesis36. Therefore, the increase of endothelial NO frequency correlated with the decrease of SO2 and the 
increase of NAD(P)H MO-1 ei might reflect respectively growth of NO production, consumption of molecular 
oxygen and oxidation of NADPH in NADP+. We could speculate that a sustained NO production may com-
pensate for dysfunction in the EDHF vasodilator activity that was found significantly lower at baseline in mice 
affected by oxidative stress compared to WT (Fig. 4a). However, further research with a greater number of animals 
and a more appropriate model for the study of the NO pathway (e.g. eNOS knockout mice) is required to elucidate 
better these aspects. Indeed, the results of the baseline and PE subgroups showed a significant correlation between 
the endothelial NO frequency and NAD(P)H MO-1 ei only at baseline (r = 0.70, p = 0.05), while the endothe-
lial NO frequency and the oxygen saturation were significantly correlated only during PE delivery (r = −0.78, 
p = 0.04), which may indicate that the two correlations are not linked to the same physiological process.
Discussion
In this work, cutaneous vasomotion and cell metabolic oscillations were examined simultaneously from live mice. 
A vasomotion phenomenon specifically mediated by NO and EDHF endothelial mechanisms5 was stimulated 
through administration of low-dose phenylephrine. Comparisons between Nrf2−/− mice affected by oxidative 
stress and WT controls revealed an opposite behaviour of vascular oscillations in the two models, indicating an 
effect of oxidative stress on microvascular reactivity. The most relevant differences were found especially for the 
endothelial EDHF oscillator, and vasomotion was more prominent in Nrf2−/− mice probably due to the activation 
of the myoendothelial feedback15 vascular modulation in response to oxidative stress.
We characterised a low-frequency metabolic oscillator (MO-1) of NAD(P)Hnormalised and RRindex signals that 
displayed different dynamics in WT and Nrf2−/− models, probably reflecting an alteration of the mitochondrial 
energetic processes due to oxidative stress. Relevant correlations were found in WT mice between metabolic and 
microvascular oscillators, highly suggesting an involvement of the cellular processes associated with fluctuations 
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of NAD(P)H concentrations (i.e. OXPHOS and glycolysis) in microvascular reactivity. These correlations were 
absent in Nrf2−/− mice suggesting an influence of oxidative stress on the interaction/coupling between cell meta-
bolic reactions and microvascular regulatory mechanisms.
Our findings indicate indirectly that cell metabolic oscillators may have an important role in modulating vas-
omotion in response to specific stimuli at least for oscillatory processes endothelium-mediated. Therefore, this 
raises interest in the study of cell mitochondrial and glycolytic oscillators to elucidate further the mechanisms 
driving the Ca2+ oscillations at the basis of vasomotion. Despite ECs seemed the microcirculation component 
mostly associated with slow metabolic oscillators, metabolic fluctuations were also correlated with neurogenic 
and myogenic components indicating a global cooperation of multiple factors during vasomotion with higher/
lower contributions depending on the type of stimulus and vascular bed. In the context of skin microcircula-
tion, primary metabolic Ca2+ oscillations coming from ECs and the EDHF may represent the key drivers and 
regulatory factors for vasomotion. Based on our results, vasomotion can be considered an adaptive mechanism 
Figure 6. Correlations in WT mice. (a) Correlations between NAD(P)H MO-1 ei and endothelial 
EDHF, endothelial NO, neurogenic, myogenic ei. (b) Correlation between RR MO-1 ai and endothelial 
EDHF ei. (c) Correlation between RR MO-1 f and blood flow. r = Pearson’s correlation coefficient. White 
squares = Baseline + PE (pooled data). Black dots = Baseline. White triangles = PE. *p ≤ 0.05, **p < 0.01.
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directed by the energetic requirements/stimuli in the environment surrounding blood vessels aimed at ensuring 
an optimal intake of nutrients (i.e. glucose) and oxygen for the production of ATP energy, rather than a process 
leading exclusively to the spontaneous pacemaker activity of VSMCs. This definition could help addressing better 
several controversial aspects, i.e. the observation of vasomotion in both healthy and diseased conditions1,2, or 
the primary involvement of ECs or VSMCs in different vascular beds1,2. These contrasting observations may be 
the result of variable energetic requirements and molecular signals in the parenchymal tissue surrounding the 
micro-vessels, depending on the degree of nutrition/oxygenation, the presence of a particular pathology, and the 
cell types involved. According to the literature, the factors released by microvascular ECs (NO, EDHF, etc.) can 
diffuse to the underlying parenchymal tissue and modulate the mitochondrial metabolism, the production of 
ROS and inflammation37. Thus, considering that the autofluorescence signals measured in this work have a prev-
alent epidermal origin, the correlations found between metabolic oscillations and vasomotion might also reflect 
the communication between skin cells and the microvascular network to fulfil the cutaneous metabolic needs in 
response to the α-adrenergic stimulus.
A shortcoming of the present research is the impossibility to extend the results on a general basis due to the 
small-scale design of the study and the restriction of the experiments exclusively to the WT and Nrf2−/− models. 
As future perspective to increase the applicability on a broader basis, further studies are required on a larger num-
ber of animals and on additional mouse models. In particular, testing a larger number of Nrf2−/− mice after chal-
lenging with high fat diet or after inducing diabetes would be useful to characterise the behaviour of the nonlinear 
biomarkers in the presence of an extensive oxidative stress load or a metabolic disease, and testing the biomarkers 
in a knockout model for the eNOS enzyme would be useful to elucidate better the role of NO.
The experiments in the present work were restricted to female mice due to limited availability of animals, 
thus another point to address in the future is also the extension of the study to male animals. The groups of 
tested mice were perfectly matched for an heterogeneous age range (36–60 weeks), which allowed making only 
genotype-related comparisons. However, this does not represent an issue because the main purpose of the current 
study was exploring the relationship between metabolic and microvascular oscillations in normal physiology and 
then use an example where metabolic function was disturbed (Nrf2−/− model). As future perspective, a longi-
tudinal study using more homogeneous aged animals could be also of interest to characterise the patterns of the 
nonlinear biomarkers for different age ranges.
The methodology used in this work can be easily translated for the concurrent study of metabolic and 
microvascular dynamics in humans and the exploration of metabolic oscillators as cardiovascular risk factors 
for diagnostic purposes. The use of LFS to monitor NAD(P)H provided some advantages, i.e. label-free mini-
mally invasive nature of the measurements, convenient combination of LFS and LDF probes for simultaneous 
recordings, portability of the technology. However, there are limitations leading to the discrete nature of LFS 
measurements, necessity to reconstruct NAD(P)Hnormalised and RRindex signals to characterise the oscillators, and 
the inability to trace the specific cellular origin of the oscillations. Furthermore, the technique was restricted 
to the investigation of low-frequency fluctuations due to discrete slow sampling of the spectra. More advanced 
technologies for the in-vivo imaging of NAD(P)H, i.e. fluorescence lifetime-based methods38–40 and multiphoton 
microscopy25,41–43, allow a better monitoring and discrimination between glycolytic and mitochondrial NAD(P)
H with high spatial-temporal resolution at cell level. Combining these methods with CWT can help studying both 
slow and fast NAD(P)H oscillators. Nevertheless, these technologies still require further implementation for the 
application on humans and for providing continuous NAD(P)H recordings, they are expensive and lacking of 
portability and device design for combining with the LDF probe to study simultaneously metabolic and micro-
vascular oscillators.
Figure 7. Correlations in Nrf2−/− mice. Correlations between endothelial NO f and NAD(P)H MO-1 ei or SO2. 
r = Pearson’s correlation coefficient. White squares = Baseline + PE (pooled data). Black dots = Baseline. White 
triangles = PE. *p ≤ 0.05, **p < 0.01.
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Methods
Animals. Animal work was conducted at the School of Medicine of the University of Dundee, after gaining 
approvals by the local ethics committee (University of Dundee Ethical Review Process). All the experimental 
procedures were performed in accordance with the UK Home Office relevant guidelines and regulations under 
the auspices of Project Licence PPL No. 60/4265. Animals included in the research were WT (n = 5) and Nrf2−/− 
(n = 6) female mice on a C57Black/6 background aged 36–60 weeks. Mice were maintained under a 12:12-h light/
dark cycle at 22.0 ± 1.0 °C and 50% humidity, and were fed ad libitum on a standard rodents chow diet regime 
and water.
Skin preparation and anaesthesia. LFS and LDF techniques are sensitive to light absorption by hair and 
skin pigmentation. Therefore, a hair-free non-pigmented intact skin is required to obtain reliable measurements. 
Forty-eight hours prior to performing the experiments, hair from the mice flanks was shaved using an electric 
shaver, and the residual hair was removed using depilatory cream (Veet, Reckitt-Benckiser). Before collecting 
measurements, mice were anaesthetised through a standard Boyle’s Apparatus to prevent movement artefacts and 
were laid on a heat mat at 37.0 °C, as described previously by us44. A light anaesthesia was maintained by deliver-
ing 1.5–2% isoflurane (Abbott Laboratories) in oxygen (1.5 L/minute) through an inhalation nose cone (Fig. 1a).
Iontophoresis. Iontophoresis allows the local delivery of vasoactive drugs in the skin microcirculation with-
out inducing systemic effects. The drug is transferred transdermally by the unidirectional movement of ions in 
a solution, through a continuous current generated by a reference electrode and a platinum electrode incorpo-
rated in a ring-shaped chamber44,45. We used an iontophoresis chamber (ION6 probe, Moor Instruments, UK) 
of 20 mm internal diameter attached to the mouse flank using double-adhesive tape, and a reference electrode 
placed underside of the animal. The chamber was filled with a 2 ml 1% phenylephrine solution, and LFS and LDF 
probes were placed at two adjacent sites on the skin area inside the chamber (Fig. 1a). LFS/LDF signals were 
measured simultaneously for 20 min, 10 min without application of electric current (baseline), and 10 min during 
delivery of PE by applying a continuous 100 μA anodal current through a controller (MIC2, Moor Instruments, 
UK) connected to the electrodes.
Laser Fluorescence Spectroscopy. LFS employs a low-power laser (1–5 mW) for the in-vivo excitation 
of cell endogenous fluorophores, i.e. NAD(P)H, allowing the detection of autofluorescence emission peaks pro-
portional to the tissue concentration of the biomarkers46–48. We assessed skin NAD(P)H autofluorescence with 
a single-point LFS probe (LAKK-M, Spe Lazma, Russia) provided with irradiating and detection sensors at a 
distance of ~1 mm for targeting a tissue volume of ~1 mm3. Discrete 10 seconds autofluorescence spectra were 
sampled from the mouse flank by a 365 nm UV excitation light (1 mW) at a rate of one spectrum every min-
ute during iontophoresis. The spectra were processed by Matlab R2015a (The MathWorks Inc.) to extract the 
amplitudes of NAD(P)H (490 nm), FAD+ (550 nm), and elastin (450 nm) peaks (Fig. 1b). The redox ratio and 
normalised NAD(P)H autofluorescence were estimated respectively according to equations 1 and 2. For the study 
of NAD(P)Hnormalised and RRindex oscillations by CWT, 20 min signals were reconstructed from the discrete data 
points (Fig. 1c) using the piecewise cubic spline interpolation method that we have previously described for 
reconstructing blood flow signals49,50. More details on signals reconstruction and NAD(P)H autofluorescence 
normalisation are provided in the Supplementary Information.
Laser Doppler Flowmetry and oxygen saturation. LDF allows the indirect measurement of blood per-
fusion by sensing the Doppler-shift in wavelength generated when a monochromatic and coherent light is backs-
cattered by moving blood cells7,8,28,33,45. We measured skin blood flow using a laser Doppler flowmeter (LAKK-M, 
Spe Lazma, Russia) provided with a probe identical to the LFS probe described above, which was calibrated 
with a fluoroplastic oscillating disk simulating Brownian motion. A 20 min LDF signal was measured during 
iontophoresis (Fig. 1d) using a 1064 nm laser with sampling frequency of 20 Hz. The multi-functional probe was 
also provided with 630 nm and 532 nm lasers, which allowed measuring the percentage skin oxygen saturation 
(SO2) according to the reflectance spectroscopy principles51. The technique is based on the analysis of the signal 
backscattered from the skin to detect the differential absorption of red and green visible lights by the oxygenated 
(oxyHb) and deoxygenated (deoxyHb) haemoglobin (Hb). The absorption is proportional to the relative molar 
concentrations of Hb fractions in the tissue, which are extracted from the backscattered spectrum by application 
of the Beer-Lambert law52:
∑μ λ ε λ= ⋅ C( ) ( ) ,
(3)a i
i i
where εi(λ) is the molar extinction coefficient of each absorber, Ci is the molar concentration of each absorber, 
and μa(λ) is the absorption coefficient. The percentage SO2 is finally estimated as follow52:
=
+
⋅ .SO oxyHb
oxyHb deoxyHb
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100%
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More details and references on how the terms of equations 3 and 4 can be extracted from the backscattered 
signal are provided in the paper by Dunaev et al.52.
Continuous Wavelet Transform. The CWT method is largely employed to analyse blood perfusion 
vasomotion dynamics in the time-frequency domain8,28,29, providing optimal frequency resolution for low fre-
quencies and good time resolution for high frequencies. We employed this method to investigate heterogeneous 
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oscillations of LDF, NAD(P)Hnormalised and RRindex signals, using a CWT with scaling factor s, time t, Morlet wave-
let function ψ and central frequency 18,28:
∫ ψ=



− 

 .−∞
∞
g s t
s
u t
s
g u du( , ) 1 ( )
(5)
CWT and the extraction of the spectral energy Ei28, amplitude Ai28 and frequency f28 from the time-averaged 
wavelet peaks were performed using Matlab R2015a (The MathWorks Inc.). Figure 3 shows examples of CWT 
scalograms and corresponding time-averaged spectra from LDF and NAD(P)Hnormalised signals.
Wavelet phase coherence. The WPCO analysis provides information on the phase relationship Cφ(ωk) 
between oscillators in the same frequency interval of two signals recorded simultaneously53. The analysis returns 
values between 0 and 1, where Cφ(ωk) ≈ 0 indicates absence of coherence, Cφ(ωk) ≈ 1 complete coherence, 
and 0 < Cφ(ωk) < 1 partial coherence53. We investigated the coherence between MO-1 of metabolic signals and 
the LDF endothelial EDHF oscillator that are located in the same frequency range. The analysis was performed 
through the WPCO code provided in the Lancaster University website http://py-biomedical.lancaster.ac.uk by 
Professor Aneta Stefanovska research group, which estimates Cφ(ωk) according to the principles described by 
Bandrivskyy et al.53 and Clemson et al.54.
Statistics. Statistical analyses were performed by R-Studio software. The Shapiro-Wilk test revealed normal 
distributions for all the variables tested in the study. Therefore, the correlations were evaluated by calculating the 
Pearson’s correlation coefficient r, differences between baseline and PE time points were tested by paired t-test, 
and differences between groups were assessed by unpaired t-test. The correlations were considered relevant for 
p ≤ 0.05 and values of r > 0.5 or < −0.5. The t-test was considered significant at p < 0.05 with a statistical power 
of 0.8.
Data Availability
All data generated or analysed during this study are included in this published article and its Supplementary 
Information file.
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